During my time in the Egger Lab at the “Medizinische Universität Wien”, I had the pleasure of working with Kristina Draganić to isolate primary macrophages from the whole blood of healthy donors.
Read More
During my time in the Egger Lab at the “Medizinische Universität Wien”, I had the pleasure of working with Kristina Draganić to isolate primary macrophages from the whole blood of healthy donors.
Read More
Julia Montague, Enrique Abarca Ríos, and Rebekka Salzmann had the opportunity to represent the FANTOM network at the 30th Congress of the European Hematology Association (EHA) in Milan.
Read More
Julia Montague, Enrique Abarca Ríos, and Rebekka Salzmann had the opportunity to represent the FANTOM network at the 30th Congress of the European Hematology Association (EHA) in Milan.
Read More
From the moment we each introduced ourselves first thing in the morning, I was struck by how engaged and informed all participants were.
Read More
My doctoral research focuses on drug-tolerant persister cells (DTPs) and drug resistance mechanisms in ALK+ anaplastic large cell lymphoma (ALCL) and other ALK+ malignancies, such as non-small cell lung cancer (NSCLC).
Read More
During my studies, I was especially drawn to biomarker discovery, focusing my Master’s thesis on investigating gene polymorphisms to improve cardiovascular drug safety.
Read More
During my studies, I was especially drawn to biomarker discovery, focusing my Master’s thesis on investigating gene polymorphisms to improve cardiovascular drug safety.
Read More
To really understand how diseases form, I realised I needed to study the human body in depth, at cellular and molecular level.
Read More
During my master’s thesis, I investigated the WIP1/PPM1D phosphatase oncoprotein as a therapeutic target for potentiating p53-dependent therapies.
Read More
I’m particularly fascinated by how metabolic changes contribute to the transformation of normal T cells into malignant ones in ALCL. My current project dives into the role of STAT proteins
Read More